Please enable JS

Discovery

Our in-house discovery team focuses on the research and discovery of immuno-oncology treatment. We have collaborations with leading academic institutions in China, including Tsinghua University and Shanghai Institute of Materia Medica, to expand our in-house research projects. We believe this team and our discovery strategy will enable us to achieve our long-term goal of commercializing our internally discovered innovative medicine for patients around the world.